| 000 | 02442cam a2200325 i 4500 | ||
|---|---|---|---|
| 001 | 17488547 | ||
| 003 | MYCC | ||
| 005 | 20250106122752.0 | ||
| 008 | 121010s2013 njua b 001 0 eng | ||
| 020 | _a9781118487471 | ||
| 040 |
_aDLC _beng _cDLC _erda _dDLC _dMYCC |
||
| 082 | 0 | 0 |
_a338.4/76151 _223 |
| 090 | 0 | 0 |
_a338.4/76151 _bLAM 2013 |
| 100 | 1 | _aLaMattina, John L. | |
| 245 | 1 | 0 |
_aDevalued and distrusted : _bcan the pharmaceutical industry restore its broken image? / _cJohn L. LaMattina, Ph.D. |
| 264 | 1 |
_aHoboken, New Jersey : _bJohn Wiley & Sons, Inc., _c[2013] |
|
| 300 |
_aix, 125 pages : _billustrations ; _c25 cm |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 8 | _aMachine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts . | |
| 520 |
_a"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"-- _cProvided by publisher. |
||
| 650 | 0 |
_aPharmaceutical industry _xCorrupt practices. |
|
| 650 | 7 |
_aMEDICAL / Pharmacology. _2bisacsh |
|
| 856 | 4 | 2 |
_3Contributor biographical information _uhttp://www.loc.gov/catdir/enhancements/fy1307/2012032915-b.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy1307/2012032915-d.html |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy1307/2012032915-t.html |
| 942 |
_2ddc _cBK |
||
| 999 |
_c209 _d209 |
||